SWIM
PTCT icon

Smallwood Wealth Investment Management’s PTC Therapeutics PTCT Stock Holding History

Smallwood Wealth Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Hold
1,683
– – 0.06% 118
2026
Q1 		$115K Hold
1,683
– – 0.06% 116
2025
Q4 		$128K Hold
1,683
– – 0.07% 104
2025
Q3 		$103K Hold
1,683
– – 0.05% 124
2025
Q2 		$82.2K Hold
1,683
– – 0.05% 126
2025
Q1 		$85.8K Buy
+1,683
New +$84K 0.05% 123

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Smallwood Wealth Investment Management's PTCT Position: Q2 2026 in Review

Smallwood Wealth Investment Management held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 1,683 shares worth $137K. The position accounts for 0.06% of the portfolio, ranked #118.

Smallwood Wealth Investment Management first reported a position in PTCT in Q1 2025 and has held it in 6 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Smallwood Wealth Investment Management held 1,683 shares of PTC Therapeutics worth $137K as of Q2 2026.
  • Smallwood Wealth Investment Management left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up 0.06% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #118 holding.
  • Smallwood Wealth Investment Management first reported a position in PTC Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.